| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Charter to Improve Patient Care in Severe Asthma
|
Menzies-Gow, Andrew
|
|
2018
|
35 |
10 |
p. 1485-1496
|
artikel
|
| 2 |
A Charter to Improve Patient Care in Severe Asthma
|
Menzies-Gow, Andrew
|
|
|
35 |
10 |
p. 1485-1496
|
artikel
|
| 3 |
An Update of Efficacy and Safety of Cetuximab in Metastatic Colorectal Cancer: A Narrative Review
|
Fornasier, Giulia
|
|
2018
|
35 |
10 |
p. 1497-1509
|
artikel
|
| 4 |
Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States
|
Seiter, Karen
|
|
2018
|
35 |
10 |
p. 1671-1685
|
artikel
|
| 5 |
Combination Antihypertensive Therapy with Perindopril and Indapamide in Patients with Essential Hypertension: Effect on Endothelial and Cognitive Markers of Vascular Improvement
|
Zheleznykh, Elena A.
|
|
2018
|
35 |
10 |
p. 1698-1712
|
artikel
|
| 6 |
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
|
Kim, Sunnie
|
|
2018
|
35 |
10 |
p. 1564-1577
|
artikel
|
| 7 |
Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
|
Kim, Sunnie
|
|
|
35 |
10 |
p. 1564-1577
|
artikel
|
| 8 |
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy
|
Purser, Molly F.
|
|
2018
|
35 |
10 |
p. 1697
|
artikel
|
| 9 |
Correction to: Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy
|
Purser, Molly F.
|
|
|
35 |
10 |
p. 1697
|
artikel
|
| 10 |
Current and Emerging Treatment Modalities for Leber’s Hereditary Optic Neuropathy: A Review of the Literature
|
Theodorou-Kanakari, Anna
|
|
2018
|
35 |
10 |
p. 1510-1518
|
artikel
|
| 11 |
Current and Emerging Treatment Modalities for Leber’s Hereditary Optic Neuropathy: A Review of the Literature
|
Theodorou-Kanakari, Anna
|
|
|
35 |
10 |
p. 1510-1518
|
artikel
|
| 12 |
Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps
|
Kalra, Sanjay
|
|
2018
|
35 |
10 |
p. 1519-1534
|
artikel
|
| 13 |
Diagnostic Accuracy of Bronchodilator Response for Asthma in a Population of South China
|
Zhang, Shichuan
|
|
2018
|
35 |
10 |
p. 1578-1584
|
artikel
|
| 14 |
Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’
|
Raffa, Robert B.
|
|
2018
|
35 |
10 |
p. 1471-1484
|
artikel
|
| 15 |
Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’
|
Raffa, Robert B.
|
|
|
35 |
10 |
p. 1471-1484
|
artikel
|
| 16 |
Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review
|
Emery, Paul
|
|
2018
|
35 |
10 |
p. 1535-1563
|
artikel
|
| 17 |
Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review
|
Emery, Paul
|
|
|
35 |
10 |
p. 1535-1563
|
artikel
|
| 18 |
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy
|
Purser, Molly F.
|
|
2018
|
35 |
10 |
p. 1686-1696
|
artikel
|
| 19 |
Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy
|
Purser, Molly F.
|
|
|
35 |
10 |
p. 1686-1696
|
artikel
|
| 20 |
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
|
Yan, Tingjian
|
|
2018
|
35 |
10 |
p. 1612-1625
|
artikel
|
| 21 |
Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data
|
Yan, Tingjian
|
|
|
35 |
10 |
p. 1612-1625
|
artikel
|
| 22 |
Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
|
Calabrò, Marco
|
|
2018
|
35 |
10 |
p. 1656-1670
|
artikel
|
| 23 |
Neuroplasticity, Neurotransmission and Brain-Related Genes in Major Depression and Bipolar Disorder: Focus on Treatment Outcomes in an Asiatic Sample
|
Calabrò, Marco
|
|
|
35 |
10 |
p. 1656-1670
|
artikel
|
| 24 |
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
|
Edwards, Roger A.
|
|
2018
|
35 |
10 |
p. 1585-1597
|
artikel
|
| 25 |
Predicting Responses to Pregabalin for Painful Diabetic Peripheral Neuropathy Based on Trajectory-Focused Patient Profiles Derived from the First 4 Weeks of Treatment
|
Edwards, Roger A.
|
|
|
35 |
10 |
p. 1585-1597
|
artikel
|
| 26 |
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
|
Naya, Ian P.
|
|
2018
|
35 |
10 |
p. 1626-1638
|
artikel
|
| 27 |
Preventing Clinically Important Deterioration of COPD with Addition of Umeclidinium to Inhaled Corticosteroid/Long-Acting β2-Agonist Therapy: An Integrated Post Hoc Analysis
|
Naya, Ian P.
|
|
|
35 |
10 |
p. 1626-1638
|
artikel
|
| 28 |
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
|
Růžičková, Olga
|
|
2018
|
35 |
10 |
p. 1713-1728
|
artikel
|
| 29 |
Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia
|
Růžičková, Olga
|
|
|
35 |
10 |
p. 1713-1728
|
artikel
|
| 30 |
Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
|
Schultz, Neil M.
|
|
2018
|
35 |
10 |
p. 1639-1655
|
artikel
|
| 31 |
Treatment Duration, Healthcare Resource Utilization, and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis
|
Schultz, Neil M.
|
|
|
35 |
10 |
p. 1639-1655
|
artikel
|
| 32 |
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension
|
Ochi, Hirofumi
|
|
2018
|
35 |
10 |
p. 1598-1611
|
artikel
|
| 33 |
72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension
|
Ochi, Hirofumi
|
|
|
35 |
10 |
p. 1598-1611
|
artikel
|
Tijdschrift beschrijving